Use of SGLT2 Inhibitors in Patients With HF With and Without Type 2 Diabetes An Endocrinologist's Perspective

被引：0
|
作者：
Butler, Javed [1 ,2 ,3 ]
Pessah-Pollack, Rachel [4 ]
机构：
[1] Baylor Scott & White Res Inst, 3434 Live Oak St,Suite 501, Dallas, TX 75204 USA
[2] Baylor Scott & White Hlth, Dallas, TX USA
[3] Univ Mississippi, Sch Med, Jackson, MS USA
[4] NYU, Sch Med, New York, NY USA
来源：
JACC-HEART FAILURE | 2024年 / 12卷 / 06期
关键词：
heart failure; SGLT2; inhibitors; type; 2; diabetes;
D O I：
10.1016/j.jchf.2024.01.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S4 / S6
页数：3
相关论文
共 50 条
  • [1] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [2] SGLT2 inhibitors also protect patients without diabetes
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (08) : 437 - 438
  • [3] In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes
    Nabrdalik, Katarzyna
    Lip, Gregory Y. H.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : JC125 - JC125
  • [4] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [5] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    Endocrine, 2016, 53 : 364 - 372
  • [6] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [7] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [8] Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes
    Mannucci, Edoardo
    Mangia, Pier Paolo
    Pradelli, Lorenzo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2020, 21 : 3 - 20
  • [9] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
    Beatrice C. Lupsa
    Silvio E. Inzucchi
    Diabetologia, 2018, 61 : 2118 - 2125
  • [10] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
    Lupsa, Beatrice C.
    Inzucchi, Silvio E.
    DIABETOLOGIA, 2018, 61 (10) : 2118 - 2125
12345